TIBER CREEK HEALTH STRATEGIES, INC.

View full entity profile (contributions, contracts, SEC) →

Lobbying Income

$25.8M

Filings

766

Unique Clients

Active Period

2011–2026

Lobbying Income by Year

Registrant-reported income from clients on LDA filings

Year	Lobbying Income	Filings	Clients
2026	$1,560,000	29	11
2025	$2,520,000	45	12
2024	$2,620,000	49	12
2023	$2,620,000	46	11
2022	$2,610,000	45	11
2021	$2,090,000	50	17
2020	$1,530,000	70	19
2019	$1,530,000	62	16
2018	$1,350,000	65	16
2017	$1,240,000	53	13
2016	$1,100,000	51	13
2015	$1,200,000	50	13
2014	$1,160,000	50	13
2013	$880,000	41	10
2012	$860,000	27	8
2011	$925,000	33	7

Top Clients

Largest clients by registrant-reported income

Client	Reported Income	Filings	Period
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)	$3,480,000	62	2011–2026
NOVARTIS	$3,480,000	61	2012–2026
GENENTECH INC	$3,270,000	64	2011–2026
AMGEN, INC.	$3,010,000	62	2011–2026
TIBER CREEK GROUP (ON BEHALF OF VERTEX PHARMACEUTICALS)	$2,140,000	64	2011–2026
ELI LILLY AND COMPANY	$1,950,000	28	2020–2026
TIBER CREEK GROUP (OBO JAZZ PHARMACEUTICALS)	$1,450,000	33	2019–2026
TIBER CREEK GROUP (ON BEHALF OF EMD SERONO, INC.)	$1,430,000	42	2016–2026
FRESENIUS MEDICAL CARE NORTH AMERICA	$1,400,000	26	2020–2026
TIBER CREEK GROUP ON BEHALF OF MERCK & CO., INC.	$1,340,000	49	2014–2026
GRAIL, LLC	$530,000	12	2024–2026
TIBER CREEK GROUP (ON BEHALF OF BRISTOL MYERS SQUIBB)	$480,000	22	2020–2025
COMPREHENSIVE HEALTH MANAGEMENT, INC.	$430,000	8	2018–2019
PECK MADIGAN JONES (ON BEHALF OF INNOVACARE, INC.)	$360,000	28	2014–2021
DAIICHI SANKYO INC	$330,000	7	2011–2012
PECK MADIGAN JONES (ON BEHALF OF MICRON TECHNOLOGY, INC.)	$200,000	23	2013–2018
PECK MADIGAN JONES (ON BEHALF OF CAPG)	$170,000	23	2014–2019
PECK MADIGAN JONES (ON BEHALF OF LEGACY COMMUNITY HEALTH SERVICES)	$100,000	28	2014–2021
PECK MADIGAN JONES (ON BEHALF OF CELGENE CORPORATION)	$70,000	10	2018–2019
PECK MADIGAN JONES (ON BEHALF OF AMERICAN SOCIETY OF CLINICAL ONCOLOGY)	$40,000	6	2019–2020
PECK MADIGAN JONES (ON BEHALF OF ASSOCIATION FOR CLINICAL ONCOLOGY)	$40,000	6	2020–2021
PECK MADIGAN JONES (ON BEHALF OF BIOSCRIP)	$30,000	10	2017–2019
ICKES AND ENRIGHT GROUP (ON BEHALF OF NORTHWEST BIOTHERAPEUTICS)	$30,000	4	2016
PECK MADIGAN JONES (ON BEHALF OF ACADIA PHARMACEUTICALS, INC.)	$20,000	3	2020–2021
PECK MADIGAN JONES (ON BEHALF OF BEIGENE USA, INC.)	$10,000	3	2020–2021

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
SENATE	572
HOUSE OF REPRESENTATIVES	102
Health & Human Services, Dept of (HHS)	4
White House Office	3
Food & Drug Administration (FDA)	2

Top Issues Lobbied

Most frequently reported lobbying issues

Issue Code	Description	Reports
Medicare/Medicaid	Medicare/Medicaid	428
Health Issues	Health Issues	339
Pharmacy	Pharmacy	141
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	44
Copyright/Patent/Trademark	Copyright/Patent/Trademark	33
Budget/Appropriations	Budget/Appropriations	25
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	23
Immigration	Immigration	13
Trade (domestic/foreign)	Trade (domestic/foreign)	6
Defense	Defense	3
Disaster Planning/Emergencies	Disaster Planning/Emergencies	3
Natural Resources	Natural Resources	2
Small Business	Small Business	2
Science/Technology	Science/Technology	1

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 842119th Congress

Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

2026 · third_quarter · Client: GRAIL, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to multi-cancer early detection screening; Issues related to H.R. 842/S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act.

Client expense: — · Firm income: $50,000

Matched citations: H.R. 842

S. 339119th Congress

A bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests.

2026 · third_quarter · Client: GRAIL, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to multi-cancer early detection screening; Issues related to H.R. 842/S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act.

Client expense: — · Firm income: $50,000

Matched citations: S. 339

H.R. 842119th Congress

Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

2026 · second_quarter · Client: GRAIL, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to multi-cancer early detection screening; Issues related to H.R. 842/S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act.

Client expense: — · Firm income: $50,000

Matched citations: H.R. 842

S. 339119th Congress

A bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests.

2026 · second_quarter · Client: GRAIL, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to multi-cancer early detection screening; Issues related to H.R. 842/S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act.

Client expense: — · Firm income: $50,000

Matched citations: S. 339

Show 21 more cited filings

H.R. 842119th Congress

Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

2026 · first_quarter · Client: GRAIL, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to multi-cancer early detection screening; Issues related to H.R. 842/S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act.

Client expense: — · Firm income: $50,000

Matched citations: H.R. 842

S. 339119th Congress

A bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests.

2026 · first_quarter · Client: GRAIL, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to multi-cancer early detection screening; Issues related to H.R. 842/S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act.

Client expense: — · Firm income: $50,000

Matched citations: S. 339

H.R. 842119th Congress

Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

2025 · fourth_quarter · Client: GRAIL, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to multi-cancer early detection screening; Issues related to H.R. 842/S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act.

Client expense: — · Firm income: $50,000

Matched citations: H.R. 842

S. 339119th Congress

A bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests.

2025 · fourth_quarter · Client: GRAIL, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to multi-cancer early detection screening; Issues related to H.R. 842/S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act.

Client expense: — · Firm income: $50,000

Matched citations: S. 339

H.R. 842119th Congress

Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

2025 · third_quarter · Client: GRAIL, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to multi-cancer early detection screening; Issues related to H.R. 842 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act.

Client expense: — · Firm income: $50,000

Matched citations: H.R. 842

H.R. 842119th Congress

Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

2025 · second_quarter · Client: GRAIL, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to multi-cancer early detection screening; Issues related to H.R. 842 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act.

Client expense: — · Firm income: $50,000

Matched citations: H.R. 842

H.R. 5547118th Congress

Maintaining Investments in New Innovation Act

2025 · first_quarter · Client: NOVARTIS

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); H.R. 5547/S. 476 - Maintaining Investments in New Innovation Act (118th Congress).

Client expense: — · Firm income: $60,000

Matched citations: H.R. 5547

S. 476118th Congress

Maintaining Investments in New Innovation Act

2025 · first_quarter · Client: NOVARTIS

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); H.R. 5547/S. 476 - Maintaining Investments in New Innovation Act (118th Congress).

Client expense: — · Firm income: $60,000

Matched citations: S. 476

H.R. 2407118th Congress

Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

2025 · first_quarter · Client: GRAIL, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to multi-cancer early detection screening; H.R. 2407 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (118th Congress).

Client expense: — · Firm income: $50,000

Matched citations: H.R. 2407

H.R. 5547118th Congress

Maintaining Investments in New Innovation Act

2024 · fourth_quarter · Client: NOVARTIS

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); H.R.5547/S. 476 - Maintaining Investments in New Innovation Act.

Client expense: — · Firm income: $60,000

Matched citations: H.R.5547

S. 476118th Congress

Maintaining Investments in New Innovation Act

2024 · fourth_quarter · Client: NOVARTIS

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); H.R.5547/S. 476 - Maintaining Investments in New Innovation Act.

Client expense: — · Firm income: $60,000

Matched citations: S. 476

H.R. 2407118th Congress

Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

2024 · fourth_quarter · Client: GRAIL, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to multi-cancer early detection screening; H.R. 2407 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act.

Client expense: — · Firm income: $50,000

Matched citations: H.R. 2407

H.R. 5547118th Congress

Maintaining Investments in New Innovation Act

2024 · third_quarter · Client: NOVARTIS

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); H.R.5547/S. 476 - Maintaining Investments in New Innovation Act.

Client expense: — · Firm income: $60,000

Matched citations: H.R.5547

S. 476118th Congress

Maintaining Investments in New Innovation Act

2024 · third_quarter · Client: NOVARTIS

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); H.R.5547/S. 476 - Maintaining Investments in New Innovation Act.

Client expense: — · Firm income: $60,000

Matched citations: S. 476

H.R. 2407118th Congress

Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

2024 · third_quarter · Client: GRAIL, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to multi-cancer early detection screening; H.R. 2407 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act.

Client expense: — · Firm income: $50,000

Matched citations: H.R. 2407

H.R. 5547118th Congress

Maintaining Investments in New Innovation Act

2024 · second_quarter · Client: NOVARTIS

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); H.R.5547/S. 476 - Maintaining Investments in New Innovation Act.

Client expense: — · Firm income: $60,000

Matched citations: H.R.5547

S. 476118th Congress

Maintaining Investments in New Innovation Act

2024 · second_quarter · Client: NOVARTIS

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); H.R.5547/S. 476 - Maintaining Investments in New Innovation Act.

Client expense: — · Firm income: $60,000

Matched citations: S. 476

H.R. 2407118th Congress

Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

2024 · second_quarter · Client: GRAIL, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to multi-cancer early detection screening; H.R. 2407 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act.

Client expense: — · Firm income: $50,000

Matched citations: H.R. 2407

H.R. 5547118th Congress

Maintaining Investments in New Innovation Act

2024 · first_quarter · Client: NOVARTIS

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); H.R.5547/S. 476 - Maintaining Investments in New Innovation Act.

Client expense: — · Firm income: $60,000

Matched citations: H.R.5547

S. 476118th Congress

Maintaining Investments in New Innovation Act

2024 · first_quarter · Client: NOVARTIS

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); H.R.5547/S. 476 - Maintaining Investments in New Innovation Act.

Client expense: — · Firm income: $60,000

Matched citations: S. 476

H.R. 2407118th Congress

Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

2024 · first_quarter · Client: GRAIL, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to multi-cancer early detection screening; H.R. 2407 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act.

Client expense: — · Firm income: $30,000

Matched citations: H.R. 2407

Source: Senate LDA

TIBER CREEK HEALTH STRATEGIES, INC. — Lobbying Disclosure | Poliscope